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Abstract 
The cAMP-dependent protein kinase A (PKA) regulates a plethora of cellular 
functions in health and disease. During angiogenesis, PKA activity in endothelial 
cells controls the transition from sprouting to vessel maturation and limits tip cell 
formation independently of Notch signaling. The molecular PKA targets mediating 
these effects remain unknown. We report a chemical genetics screen identifying 
endothelial-specific substrates of PKA in human umbilical vein endothelial cells 
(HUVEC). We identified ATG16L1, a regulator of autophagy, as novel target of PKA. 
Biochemical validation, mass spectrometry and peptide spot arrays revealed that 
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PKA phosphorylates ATG16L1α at Ser268 and ATG16L1β at Ser269. The 
phosphorylations drive degradation of ATG16L1 protein. Knocking down PKA or 
inhibiting its activity increased ATG16L1 protein levels and endothelial autophagy. In 
vivo genetics and pharmacological experiments demonstrated that autophagy 
inhibition partially rescues vascular hypersprouting caused by PKA deficiency. We 
propose that endothelial PKA activity restricts active sprouting by reducing 
endothelial autophagy through phosphorylation of ATG16L1. 
 
Introduction 
Angiogenesis is the process of new blood vessels formation from pre-existing 
vessels via sprouting and remodeling. Blood vessels are crucial for tissue growth 
and physiology in vertebrates since they are the pipelines for oxygen and nutrients 
supply and for distribution of cells, such as of the immune system. Inadequate vessel 
formation and maintenance as well as abnormal vascular remodeling cause, 
accompany or aggravate many disease processes including myocardial infarction, 
stroke, cancer, and inflammatory disorders(Geudens & Gerhardt, 2011; Potente, 
Gerhardt, & Carmeliet, 2011). 
Sprouting angiogenesis is a multistep process encompassing sprout initiation, 
elongation, anastomosis and final vascular network formation(Geudens & Gerhardt, 
2011). Multiple molecular pathways have been identified to regulate sprouting 
angiogenesis; the most investigated are vascular endothelial growth factor (VEGF) 
and Notch/delta-like 4(DLL4) signalling. Whereas VEGF initiates angiogenesis 
through activating VEGF receptor 2 (VEGFR2), thereby guiding angiogenic sprouting 
and tip cell formation as well as stalk cell proliferation(Ferrara, Gerber, & LeCouter, 
2003; Gerhardt et al., 2003), Notch and its ligand delta-like 4 (DLL4) limit tip cell 
formation and angiogenic sprouting(Hellström et al., 2007; Leslie et al., 2007; Lobov 
et al., 2007; Suchting et al., 2007). VEGF and Notch/DLL4 pathways co-operate to 
form a fine-tuned feedback loop to balance tip and stalk cells during developmental 
angiogenesis and to maintain vascular stabilization. In addition, 
PI3K/AktMAP4K4(Vitorino et al., 2015), ephrins and Eph receptors(Cheng, Brantley, 
& Chen, 2002), hedgehog signalling(Pola et al., 2001), YAP/TAZ(Kim et al., 2017; 
Neto et al., 2018), BMP signalling(Vion et al., 2018) and other pathways also 
regulate various aspects of angiogenesis. 
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Recently, we identified endothelial cAMP-dependent protein kinase A (PKA) as a 
critical regulator of angiogenesis during vascular development in vivo. Inhibition of 
endothelial PKA results in hypersprouting and increased numbers of tip cells, 
indicating that PKA regulates the transition from sprouting to quiescent 
vessels(Nedvetsky et al., 2016). However, the PKA targets mediating these effects 
remained unknown. 
Here, we established a chemical genetics approach based on the mutation of a 
‘‘gatekeeper residue’’ of the ATP-binding pocket of a protein kinase to identify 
endothelial-specific substrates of PKA. We verified autophagy-related-protein-16-like 
1(ATG16L1) as a substrate of endothelial PKA and revealed that phosphorylation of 
ATG16L1 facilitates its degradation. In vivo experiments showed that autophagy 
inhibition partially rescued the hypersprouting and increased tip cell numbers caused 
by PKA deficiency.  
 
Results  
Screen for novel substrates of endothelial PKA  
In order to identify direct substrates of endothelial PKA, we employed a chemical 
genetics approach(Allen, Lazerwith, & Shokat, 2005). The ATP-binding pocket of 
kinases contains a conserved “gatekeeper residue”, which in wild type (WT) kinases 
is usually a methionine or phenylalanine. Engineered analogue specific (AS) kinases 
replace this “gatekeeper residue” with a smaller amino acid (glycine or alanine), 
enabling the AS-kinases to accept ATP analogues (or ATPγS analogues) that are 
modified at the N6 position with bulky groups as (thio-)phosphodonors. In contrast, 
WT-kinases poorly use these analogues. Once the substrates are 
thiophosphorylated by AS-kinases, they can be further alkylated and therefore 
recognized by a thiophosphate ester-specific antibody(Alaimo, Shogren-Knaak, & 
Shokat, 2001; Allen et al., 2007, 2005; Banko et al., 2011). To generate AS-PKACα, 
we mutated the methionine 120 to a glycine residue. Testing seven different variants 
of N6-substituted bulky ATPγS analogues, we identified 6-cHe-ATPγS as the best 
thiophosphodonor for AS-PKACα substrates in HUVEC lysates (Figure S1). 
To identify endothelial substrates of PKACα, HUVECs expressing WT-PKACα or AS-
PKACα were lysed in kinase lysis buffer(KLB) and the thiophosphorylation reaction 
with 6-cHe-ATPγS was performed. After alkylation with p-Nitrobenzyl mesylate 
(PNBM), thiophosphorylated proteins were immunoprecipitation with rProtein G 
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Agarose beads coupled to the thioP antibody (Figure 1A). For quality control, one 
thirtieth of the protein on agarose beads was eluted for Western blot analysis, and 
the same amount was used for gel silver staining (Figure 1B). The rest was 
subjected to mass spectrometry analysis. Two independent experiments were 
performed. Candidate endothelial PKA targets were identified as peptides that were 
at least 2-fold (log ratio(AS/WT)>1) enriched in the AS-PKACα samples compared to 
WT- PKACα samples in both experiments.  
The ninety-seven proteins identified in both experiments (Table S1) included several 
known PKA substrates such as NFATC1(Niswender et al., 2002), VASP(Anton et al., 
2014; Butt et al., 1994; Profirovic, Gorovoy, Niu, Pavlovic, & Voyno-Yasenetskaya, 
2005), PRKAR2A and  PRKAR2B(Manni, Mauban, Ward, & Bond, 2008) indicating 
that the chemical genetic screen was a feasible approach to identify PKA substrates. 
Thirty proteins with at least 8-fold enrichment (log ratio(AS/WT)>3) are listed 
according to their log ratio(AS/WT) value in Table 1, presenting the most likely direct 
substrates of PKA in this screen.  
To validate novel candidate PKACα substrates, we overexpressed WT-PKACα or 
AS-PKACα together with flag- or GFP- tagged candidate proteins in 293T cells, and 
used the 6-cHe-ATPγS as thiophosphate donor to thiophosphorylate substrates in 
lysates as described above. Lysate immunoprecipitation was carried out with M2 
anti-flag beads or anti-GFP antibody coupled agarose beads, and the immune 
complexes were probed by western blot using thiophosphate antibody. The known 
PKA substrate NFATC1 served as a positive control. Five selected new candidate 
proteins (PPP1R12C, ATG16L1α, DDX17, ANKRD40 and ATG5) out of ninety-seven 
proteins were tested; four of these five proteins were confirmed to be 
thiophosphorylated by AS-PKACα, indicating that they are indeed direct substrates 
of AS-PKACα (figure 1C). Only ATG5 was not thiophosphorylated by AS-PKACα in 
the validation of the screen (figure 1C). Bioinformatic analysis of ATG5 amino acids 
sequence also failed to identify a consensus PKA substrate motif (R-R/K-X-S/T;K/R-
X1-2-S/T)(Kennelly & Krebs, 1991). Since ATG5 directly binds to 
ATG16L1(Matsushita et al., 2007; Noboru Mizushima, Noda, & Ohsumi, 1999), it 
likely co-precipitated with ATG16L1 in our screen.  
ATG5 and ATG16L1 are conserved core components of the autophagy process, and 
PKA activity has been shown to negatively regulate autophagy in S. cervisiae and 
mammalian cells through phosphorylation of ATG1/ULK1(Noboru Mizushima, 2010). 
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ATG16L1 however has not previously been identified as a PKA target, prompting us 
to further investigate this interaction and the potential regulatory role of PKA and 
autophagy in endothelial sprouting.  
 
PKACα phosphorylates ATG16L1α at S268 and ATG16L1β at S269 
To identify the PKACα phosphorylation sites in ATG16L1, we spot-synthesized 25-
mer overlapping peptides that cover the entire ATG16L1 protein. The peptide array 
was subjected to an in vitro PKA phosphorylation assay. Three peptides of the 
ATG16L1α and 7 peptides of ATG16L1β were higher phosphorylated compared to 
the negative control (figure 2A). The common amino acid sequences included in the 
phosphorylated peptides predicted Ser268 in ATG16L1α and Ser269 as well as 
Ser287 in ATG16L1β as potential PKA phosphorylation sites (figure 2B). Indeed 
serine to alanine mutation S268A in ATG16L1α and S269A mutation in ATG16L1β 
resulted in a loss of AS-PKACα thiophosphorylation of these two ATG16L1 isoforms 
(figure 2C and 2D). Moreover, LC-MS/MS analysis demonstrated phosphorylation of 
ATG16L1α at S268 and of ATG16L1β at S269 (figure 2E and 2F). Of note, 
thiophosphorylation was converted to normal phosphorylation by 1% TFA acid-
catalyzed hydrolysis during sample preparation for LC-MS/MS, thus identifying the 
target sites as phosphorylated, not thiophosphorylated (figure S2). Together, these 
results demonstrate that S268 and S269 are the PKACα phosphorylation sites of 
ATG16L1α and ATG16L1β, respectively. 
 
PKACα regulates ATG16L1 by phosphorylation-dependent degradation  
Phosphorylation is one of the most widespread types of post-translational 
modification, and is crucial for signal transduction(C. Manning, D.B. Whyte, R. 
Martinez, T. hunter, 2002; Hunter, 1995; Ubersax & Ferrell, 2007). Previous research 
demonstrated that phosphorylation can regulate protein degradation by controlling its 
stabilization(Bullen et al., 2016; Geng, Wittwer, Dittrich-Breiholz, Kracht, & Schmitz, 
2009; Hwang, Lee, & Kwon, 2009). To determine whether phosphorylation of 
ATG16L1α by PKA regulates protein stability, we overexpressed ATG16L1αWT and 
the mutant ATG16L1αS268A in HUVECs. To activate PKA, HUVECs were treated with 
the PKA specific activator 6-Bnz-cAMP. Using cycloheximide (CHX) to prevent new 
protein synthesis allowed us to detect the degradation of ATG16L1αWT and 
ATG16L1αS268A over time. Western blot analysis showed that most of the 
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ATG16L1αWT degraded after 12 hours, whereas ATG16L1αS268A remained largely 
stable (Figure 3A-3C), suggesting that the phosphorylation of ATG16L1α at site 
Ser268 by PKA promotes degradation. For ATG16L1β, Ser269 phosphorylation 
exhibited a similar function (figure 3D-3F). In accordance, depleting PKACα in 
HUVECs by shRNA led to accumulation of ATG16L1 (figure 3G). Moreover, in 
endothelial cells isolated from dnPKAiEC mice (Prkar1aTg/+ crossed with Cdh5-
CreERT2 mice expressing tamoxifen inducible Cre recombinase under control of 
endothelial specific Cdh5 promotor), ATG16L1 protein was also increased compared 
to endothelial cells isolated from Cdh5-CreERT2 control mice (figure 3H). Taken 
together, these results indicate that PKACα regulates ATG16L1 by phosphorylation-
dependent degradation. 
 
Inhibition of autophagy partially normalizes the vascular phenotype caused by 
PKA-deficiency  
ATG16L1 is an important component of the ATG16L1-ATG5-ATG12 protein complex, 
required for LC3 lipidation and autophagosome formation. Both LC3 lipidation and 
autophagosome formation represent essential steps in autophagy (Kuma, Mizushima, 
Ishihara, & Ohsumi, 2002; Levine & Kroemer, 2008; Matsushita et al., 2007; N. 
Mizushima, 2003; Noboru Mizushima et al., 1999). Accumulation of ATG16L1 upon 
PKA knock down resulted in increased levels of the positive autophagy marker LC3II 
whilst reducing the negative autophagy marker p62 in HUVECs (figure 3G). Since 
ATG16L1 protein levels in endothelial cells isolated from dnPKA mice were also 
increased, we hypothesized that increased autophagy in endothelial cells may 
contribute to the vascular phenotype in these mice. If so, inhibiting autophagy could 
potentially normalize vascular hypersprouting in dnPKAiEC mice. To test this 
hypothesis, we treated both wild type and dnPKAiEC mice with the autophagy 
inhibitor chloroquine (CQ), performed retinal staining for isolectin B4 (IB4, membrane 
staining) and the tip cell specific marker ESM1, and quantified the IB4 and ESM1 
positive areas. No significant difference were observed between wild type mice 
treated with PBS or CQ on both the vascular plexus and tip cells. However, CQ 
treatment partially rescued both the hyperdense vascular plexus front and the 
increasing tip cells in dnPKAiEC mice (figure 4A-4C, fgure S3A). To confirm the 
specificity of this rescue genetically, we crossed the ATG5 conditional knock out 
mice ATG5ECKO (ATG5flox/flox mice crossed with Cdh5-CreERT2 mice) with dnPKAiEC 
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mice. Retinal stainings demonstrated that ATG5 deletion in endothelial cells in vivo, 
which shuts down autophagy, partially normalizes the hypersprouting phenotype of 
dnPKAiEC mice(figure 4D-4F, fgure S3B). Together these results suggest that PKA 
regulates the switch from sprouting to stabilization of nascent vascular plexuses by 
limiting endothelial autophagy levels via ATG16L1 degradation. 
 
Discussion 
Our chemical genetics screen and biochemical analysis identified ATG16L1 as novel 
target of PKA activity in endothelial cells. The combined results demonstrate that 
PKA activity inhibits autophagy in culture human vein endothelial cells (HUVEC) via 
the phosphorylation of ATG16L1, which accelerates its degradation. In cultured 
bovine aortic endothelial cells, induction of autophagy by overexpression of ATG5 
has been shown to promote in vitro vascular tubulogenesis, whereas ATG5 silencing 
suppressed this morphogenic behaviour(Du et al., 2012). In mice, inhibition of 
autophagy by bafilomycin, or genetic beclin heterozygosity as well as ATG5 
knockout impairs angiogenesis post myocardial infarction, whereas the angiogenic 
factor AGGF1 enhances therapeutic angiogenesis through JNK -mediated 
stimulation of endothelial autophagy(Lu et al., 2016). Angiogenesis during tissue 
regeneration in a burn wound model also relied on induction of endothelial 
autophagy, by driving AMPK/AKT/mTOR signaling (Liang et al., 2018), together 
suggesting that autophagy regulation may represent a critical determinant of the 
extent of vascular sprouting. The identification of ATG16L1 as a direct target of PKA 
therefore raises the hypothesis that the dramatic hypersprouting phenotype in 
dnPKAiEC mouse retinas deficient in endothelial PKA activity may result from 
exuberant endothelial activation of autophagy. Both chemical inhibition of autophagy 
and genetic endothelial inactivation of ATG5 partially normalized the hypersprouting 
phenotype in dnPKAiEC mice, suggesting that indeed the activation of autophagy in 
dnPKAiEC mice contributes to vascular hypersprouting. However, the failure to fully 
normalize vascular patterning by autophagy inhibition indicates that additional PKA 
targets and mechanisms may be involved. Our mass spectrometry analysis identified 
a list of presumptive endothelial PKA substrates, which will potentially also be 
involved in angiogenesis. For example, we identified RAPGEF2 as a candidate 
target, deficiency of which causes embryonic lethality at E11.5 due to yolk sac 
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vascular defects(Satyanarayana et al., 2010), very similar the yolk sac phenotype in 
dnPKAiEC  embryos(Nedvetsky et al., 2016). Similarly the potential target Rock2 has 
a well known role in regulating endothelial functions in angiogenesis(Liu et al., 2018; 
Montalvo et al., 2013; Seto, Chang, Jenkins, Bensoussan, & Kiat, 2016; Shimizu et 
al., 2013). Further studies will need to validate all the listed targets and establish 
which of these exert critical endothelial functions, and under what conditions. 
An alternative explanation for the partial rescue of the dnPKAiEC phenotype by 
inhibition of autophagy could lie in additional functions of ATG16L1 itself. Although 
ATG16L1 plays an essential role in autophagy, and is part of a larger protein 
complex ATG16L1-ATG5-ATG12 that is necessary for autophagy, ATG16L1 is also 
involved in the production of inflammatory cytokines IL-1β and IL-18 and exerts anti-
inflammatory functions during intestinal inflammation (Cadwell et al., 2008; Diamanti 
et al., 2017; Saitoh et al., 2008; Sorbara et al., 2013). IL-1β promotes angiogenesis 
by activating VEGF production during tumor progression(Carmi et al., 2013; Voronov 
et al., 2003), while IL-18 suppresses angiogenesis in cancer(Cao, Farnebo, Kurimoto, 
& Cao, 1999; Xing et al., 2016; Yang, Chen, Lu, Li, & Lin, 2010). How ATG16L1 
regulates angiogenesis through inflammatory cytokines and whether this regulation 
operates downstream of PKA activity in vivo requires further investigation.  
Intriguingly, our rescue experiments show that in wild type mice, inhibition of 
autophagy has no significant effect on developmental retinal angiogenesis. This 
could indicate that autophagy in developmental angiogenesis, unlike in pathological 
angiogenesis and post-ischemic tissue responses, is not very active. 
Although, to our knowledge, this is the first identification of ATG16L1 as a PKA target 
and the first indication that PKA regulates autophagy in endothelial cells, PKA has 
previously been identified as regulator of autophagy. For example, PKA reduces 
autophagy through phosphorylation of ATG13 in Saccharomyces 
cerevisiae(Hundsrucker et al., 2006), and through phosphorylation of LC3 in 
neurons(Cherra et al., 2010). In our research, ATG16L1 was identified as a novel 
direct PKA substrate in endothelial cells, but not ATG13 or LC3. Mechanistically, the 
phosphorylation of ATG16L1 by PKA accelerates its degradation, and consequently 
decreases autophagy levels in endothelial cells. The finding of different components 
of the autophagy pathway as targets of PKA identified in yeast and various 
vertebrate cell populations raises the intriguing possibility that although the principle 
regulatory logic of PKA in autophagy is conserved, different protein targets mediate 
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this effect in different cells or organisms. In addition, or alternatively, this regulation 
carries multiple levels of redundancy, and the individual studies simply identify the 
most prevalent targets within the respective cell types. The fact that also ATG16L1 
comes in two splice variants that are both targeted by PKA in endothelial cells lends 
some strength to this idea. 
ATG16L1 can itself be regulated by multiple phosphorylation events by distinct 
kinases, with opposing effects on protein stability and autophagy. ATG16L1 can be 
phosphorylated at Ser139 by CSNK2 and this phosphorylation enhances its 
interaction with the ATG12-ATG5 conjugate(Song et al., 2015). IKKα promotes 
ATG16L1 stabilization by phosphorylation at Ser278(Diamanti et al., 2017). In 
addition, phospho-Ser278 has similar functions as phospho-Thr300, since both 
phospho-mutants ATG16L1S278A  and ATG16L1T300A accelerate ATG16L1 
degradation by enhancing caspase 3 mediated ATG16L1 cleavage(Diamanti et al., 
2017; Murthy et al., 2014). In contrast, our finding suggest that the PKA target sites 
Ser268 in ATG16L1α (or Ser269 in ATG16L1β) work in the opposite way of Ser278 
and Thr300; ATG16L1αS268A (and ATG16L1βS269A) are more stable than ATG16L1WT. 
Furthermore, PKA deficiency also stabilizes ATG16L1 in endothelial cells in vivo and 
in vitro. Taken together, it appears that the different phosphorylation sites of 
ATG16L1 play different roles in fine tuning protein stability under the influence of 
alternative upstream kinases, and thereby adapt autophagy levels. Given the 
increasing insights into the role of autophagy in cell and tissue homeostasis and in 
disease, it will be of great interest to investigate whether the newly identified 
regulation by PKA extends beyond developmental angiogenesis into 
pathomechanisms associated with endothelial dysfunction. 
Finally, on a technical note, the chemical genetics approach developed by Shoktat 
and colleagues(Alaimo et al., 2001; Allen et al., 2007, 2005) has successfully been 
used in other cell types, but to our knowledge, this is the first report on direct 
endothelial PKA targets. Our initial attempts using published cell lysate conditions 
based on RIPA buffer however failed to identify differences in thiophosphorylation 
when comparing AS-PKA expressing cells to WT-PKA expressing cells. Our buffer 
optimization revealed that RIPA buffer limits the activity of PKA kinase, whereas our 
new kinase lysis buffer (see methods) allows effective substrate phosphorylation, 
thus giving rise to strong signals in AS-PKA samples. This optimization will hopefully 
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be valuable for researchers aiming to utilize this approach for additional chemical 
genetic kinase substrate screens in the future.  
Materials and Methods 
Cell culture 
Human Umbilical Vein Endothelial Cells (HUVECs) were freshly isolated and 
cultured in Endothelial Cell Growth Medium (Ready-to-use) (Promocell), passage 3 
to 5 were used for experiments. HEK293T cells were cultured in Dulbecco's Modified 
Eagle Medium (DMEM, Thermo Fisher) with 10% Fetal Bovine Serum (FBS, Thermo 
Fisher) and 50 U/ml penicillin and 50 mg/ml streptomycin (Thermo Fisher) in 5% CO2 
at 37 C.  
Plasmid Construction 
Lentivirus vector pRRLsin.PPT.CMV.flag.MCS was generated by resctrictional 
cloning of a sequence coding flag-tag into the pRRLsin.PPT.CMV.MCS vector at 
XbaI and XmaI restriction sites. It was used to generate flag-tagged constructs. 
PKACa, ANKRD40 and ATG5 were amplified from total RNA extracted from 
HUVECs and cloned into the pRRLsin.PPT.CMV.flag.MCS vector. pECE-M2-
PPP1R12A wt, EGFPC1-huNFATc1EE-WT, pDESTmycDDX17, pMRX-IP/SECFP-
hATG16L1 were purchased from Addgene. pDESTmycDDX17, pMRX-IP/SECFP-
hATG16L1 and subcloned to vector pRRLsin.PPT.CMV.flag.MCS. PKACaM120G, 
ATG16L1 S268A, ATG16L1 S269A, ATG16L1 S287A, ATG16L1 S269A& 
S287A were generated by site-directed mutagenesis using Q5® Site-Directed 
Mutagenesis Kit (NEB). pLKO.1-TRC cloning shRNA vector (addgene) was used to 
clone PKACa shRNA constructs targeting sequence: 
TAGATCTCACCAAGCGCTTTG and TCAAGGACAACTCAAACTTAT. 
 
Lentivirus production and infection  
For lentivirus production, HEK293T cells, seeded in 150 mm dishes, were 
transfected with flag-tagged constructs, psPAX2 and pMD2.G using X-tremeGENE 
HP (Roche) as transfection reagent. Medium was changed 12-16 hours after 
transfection. Lentivirus-containing medium was collected in 24-48 hours afterwards 
.CC-BY 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/573683doi: bioRxiv preprint first posted online Mar. 12, 2019; 
  
and filtered through 0.45 filters. Lentivius titers were determined with Lenti-X™ p24 
Rapid Titer Kit (Clontech). To infect HUVEC, lentivirus (MOI 20-50) and polybrene 
(final concentration 8g/ml) was added to cells for 18-22hours, and then the cells 
were washed with PBS and replaced the medium with fresh EGM2.  
 
Protein extraction and Western Blot  
Cells were lysed in RIPA buffer contained protease inhibitor cocktail and 
PhosSTOP™ (Roche). Protein concentrations were measured by Pierce™ BCA 
Protein Assay Kit. Samples were further diluted with SDS-loading buffer and SDS-
PAGE was performed using NuPAGE™ 4-12% Bis-Tris Protein Gels (Invitrogen). 
Proteins were tranferred to nitrocellulose membrane with iBlot 2 Dry Blotting System 
(Thermos Fisher) or to PVDF membranes by wet blotting. Membranes were blocked 
with 5% nonfat milk in TBST and primary antibodies were incubated overnight at 4C 
or 1.5 hours at room temperature. HRP-conjugated secondary antibodies were 
diluted and incubated 1 hour at room temperature. SuperSignal West Pico 
Chemiluminescent Substrate(Thermos Fisher) was used for imaging. Following 
antibodies were used: rabbit anti-thiophosphate ester (ab92570,1:5000) was from 
Abcam, goat anti-β-actin (sc-1615,1:2000) antibody, chicken anti-goat IgG-HRP (sc-
516086,1:5000) were from Santa Cruz Biotechnology, rabbit anti-GAPDH 
(#2118,1:1000), rabbit anti-PKACa (#4782,1:1000), rabbit anti-ATG16L1 
(#8089,1:1000), rabbit anti-p62 (#8025,1:1000), rabbit anti-LC3 (#3868,1:1000) 
antibodies and anti-rabbit IgG, HRP-linked antibody (#7074,1:2000) were from Cell 
Signaling, rabbit anti-flag (F7425,1:1000) and mouse anti-flag (F3165,1:1000) were 
from Sigma and rabbit anti-GFP (A11122,1:1000) was from Invitrogen. Peroxidase 
affinipure donkey anti-mouse IgG (715-035-151,1:2000) was from Jackson Immuno 
Research. 
 
Chemical Genetic Screen and validation of PKA substrates 
HUVECs (6 10cm-dishes each containing 1x106 cells) were infected with lentivirus 
encoding either flag-PKACa WT (as negative control) or flag-PKACa M120G. 48 
hours after infection, cells were stimulated with Sp-8-CPT-cAMPS (Biolog) for 10 
minutes, then lysed in kinase lysis buffer (1% NP40, 142 mM NaCl, 25 mM Tris-HCl 
(pH 7.5), 5 mM -glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3VO4, 10 mM 
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MgCl2) with protease inhibitor cocktail on ice for 20 minutes and spun (16,000g x 
10min) to remove cell debries. 3.5 mM GTP and 350 M 6-cHe-ATPγS (Biolog) were 
added to the lysates. After 30 min incubation at 30C, 2.5 mM p-Nitrobenzyl 
mesylate (PNBM, Abcam) was added and the reaction was incubated for additional 2 
hours at room temperature. PNBM was removed by Zeba™ Spin Desalting Columns, 
7K MWCO (Thermo Fisher) and samples were washed with IP buffer (1% NP40, 150 
mM NaCl, 50 mM Tris-HCl (pH 7.5), 0.5% sodium deoxycholate). The protein 
fractions were precleared by incubation with Recombinant Protein G Agarose for one 
hour at 4C. The precleared samples were then incubated with anti-thiophosphate 
ester antibody (51-8; Abcam) coupled to Recombinant Protein G Agarose coupled 
gently rocking overnight at 4C. The agarose beads were washed 4 times with IP 
buffer. 1/30 of the washed beads was boiled in SDS sample loading buffer for 
western blot detection or silver staining. The rest samples were used for mass 
spectrometry analyze. 
For validation of the identified substrates, 293T cells (1.5x106 on a 6cm dish) were 
transfected with 0.5g pRRL PKACa WT or pRRL PKACaM120G and 1.5 g of 
indicated candidate substrate using X-tremeGENE HP DNA transfection reagent 
(Roche). 30 hours after transfection, cells were stimulated with Sp-8-CPT-cAMPS 
(Biolog) for 10 minutes, lysated and treated as described above. 
Silver staining 
Silver staining was performed using Pierce™ Silver Stain Kit (Thermo Fisher,24600) 
according to the manufacturer’s protocol. Briefly, the SDS-page gel was washed in 
ultrapure water and fixed by fixing solution(30% ethanol,10% acetic acid) for 30 
minutes. After incubating the gel in sensitizer working solution(provided in the kit) for 
1 minutes, silver stain enhancer(provided in the kit) was added for another 5 minutes. 
Subsequently, the gel was incubated with developer working solution(provided in the 
kit) for 2-3 minutes, before stopping the reaction with stop solution(provided in the 
kit). 
Mass spectrometry to identify new PKA substrates and phosphorylation sites 
For mass spectrometric analysis to identify new PKA substrates, samples were 
prepared by chemical genetical approach as described above, each sample was run 
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on a stacking SDS-PAGE collecting all proteins in a single band. After coomassie 
blue staining, the minced gel pieces were digested with trypsin based on 
Shevchenko et al. (Shevchenko, Tomas, Havliš, Olsen, & Mann, 2007) in an 
automated fashion using a PAL robot (Axel Semrau / CTC Analytics). Samples were 
measured on an LTQ Orbitrap VELOS mass spectrometer (Thermo) connected to a 
Proxeon nano-LC system (Thermo). Five microliters of the sample was loaded on a 
nano-LC column (0.074 x 250 mm, 3 mm Reprosil C18; Dr. Maisch) and separated 
on a 155 min gradient (4%–76% acetonitrile) at a flow rate of 0.25 ml/min and 
ionized using a Proxeon ion source. Mass spectrometric acquisition was done at a 
resolution of 60,000 with a scan range of 200-1,700 m/z in FTMS mode selecting the 
top 20 peaks for collision-induced dissociation fragmentation. Tandem mass 
spectrometric scans were measured in ion-trap mode with an isolation width of  2 
m/z and a normalized collision energy of 40. Dynamic exclusion was set to 60 s. For 
data analysis, the MaxQuant software package version 1.5.2.8(Cox & Mann, 2008) 
was used. Carbamidomethylation on cysteine was set as a fixed modification and 
oxidized methionine, acetylated N-termini and phosphorylation as variable 
modifications. An FDR of 0.01 was applied for peptides and proteins and the 
Andromeda search(Cox et al., 2011) was performed using a mouse Uniprot 
database (August 2014). MS intensities were normalized by the MaxLFQ algorithm 
implemented in MaxQuant(Cox et al., 2014). MaxLFQ-normalized intensities among 
the replicates of the groups to be related were used for comparison. For downstream 
analysis R was used to calculate fold changes and t-statistics.  
For mass spectrometric analysis to identify phosphorylatin sites of ATG16L1, purified 
thiophosphorylated ATG16L1 proteins on beads were washed 3 times with 800 µl IP 
buffer followed by 3 times washing with 800 µl digestion buffer (20 mM Tris pH 8.0, 2 
mM CaCl2) and dried. The washed beads were resuspended in 150 µl digestion 
buffer and incubated for 4 hours with 1 µg trypsin (Promega, catnr: V5111) at 37˚C. 
Beads were removed, another 1 µg of trypsin was added and proteins were further 
digested overnight at 37˚C. Peptides were acidified with 1% TFA and purified on 
Omix C18 tips (Agilent, catnr. A57003100), dried and re-dissolved in 20 µl loading 
solvent (0.1% TFA in water/acetonitrile (98:2, v/v)). Five microliters of the peptide 
mixture was injected for LC-MS/MS analysis on an Ultimate 3000 RSLC nano LC 
(Thermo, Bremen, Germany) in-line connected to a Q Exactive mass spectrometer 
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(Thermo). Trapping was performed at 10 μl/min for 4 min in loading solvent on a 100 
μm internal diameter (I.D.) × 20 mm trapping column (5 μm beads, C18 Reprosil-HD, 
Dr. Maisch, Germany) and the sample was loaded on a reverse-phase column 
(made in-house, 75 µm I.D. x 220 mm, 1.9 µm. Peptides were eluted by a linear 
increase from 2 to 55% solvent B (0.08% formic acid in water/acetonitrile (2:8, v/v)) 
over 120 minutes at a constant flow rate of 300 nl/min. The mass spectrometer was 
operated in data-dependent mode, automatically switching between MS and MS/MS 
acquisition. Full-scan MS spectra (400-2000 m/z) were acquired at a resolution of 
70,000 in the orbitrap analyzer after accumulation to a target value of 3,000,000. The 
five most intense ions above a threshold value of 17,500 were isolated (window of 
2.0 Th) for fragmentation at a normalized collision energy of 25% after filling the trap 
at a target value of 50,000 for maximum 80 ms. MS/MS spectra (200-2000 m/z) were 
acquired at a resolution of 17,500 in the orbitrap analyzer.  Raw LC-MS/MS data files 
were searched against the human proteins in the Uniprot/Swiss-Prot database 
(database version of September 2017 containing 20,237 human sequences, 
downloaded from www.uniprot.org). The mass tolerance for precursor and fragment 
ions were set to 4.5 and 20 ppm, respectively, during the main search. Enzyme 
specificity was set as C-terminal to arginine and lysine, also allowing cleavage at 
proline bonds with a maximum of two missed cleavages. Variable modifications were 
set to oxidation of methionine residues, acetylation of protein N-termini, 
phosphorylation and thiophosphorylation of serine, threonine and tyrosine residues. 
The minimum score for modified peptides was set to 40. The S-lens RF level was set 
at 50 and we excluded precursor ions with single, unassigned and charge states 
above five from fragmentation selection. 
Peptide arrays, Peptide SPOT assay of ATG16L1 phosphorylation sites 
screening 
Automatic peptide SPOT synthesis was carried out as described 
previously(Hundsrucker et al., 2006, 2010; Maass et al., 2015; Stefan et al., 2007). 
Fmoc-protected amino acids (Merck Millipore) and amino-modified acid-stable 
cellulose membranes with PEG-spacers (Intavis) were used for peptide spots 
synthesis on an Intavis ResPep-SL device. 
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For phosphorylation of the peptides by PKA(Maass et al., 2015), the membranes 
were activated in ethanol, blocked in blocking buffer (5 % milk in TBS-T: Tris-HCl, 10 
mM; NaCl, 150 mM; Tween 20, 0.05 %; pH 7.4) for 3 h at room temperature, and 
washed twice with incubation buffer (Tris-HCl, 50 mM pH 7.4; MgCl2, 5 mM; ATP, 
100 µM). His-tagged recombinant catalytic subunits (vector pET46) were purified 
from E. coli (strain Rosetta D3) as described(Maass et al., 2015; Schäfer et al., 
2013). The membranes were incubated with the recombinant protein (1 nM) or with 
the cAMP-dependent protein Kinase, catalytic subunit (Promega V5161) (1nM) in 
incubation buffer (1 h, 30°C), washed three times with TBS-T, and phosphorylated 
serines were detected with PKA phosphosubstrate antibody directed against the 
consensus site RRX p(S/T) (Cell Signaling Technology, 100G7E, rabbit mAB #9624) 
in blocking buffer overnight at 4°C(Christian et al., 2011). The membranes were 
washed three times with TBS-T, and a secondary horseradish peroxidase (HRP)-
coupled donkey anti-rabbit antibody (#711-036-153; Jackson Immuno Research) 
was added (3 h, RT). After three washs with TBS-T, an ECL system (Immobilon™ 
Western substrate, Merck Millipore) and an Odyssey FC device (Li-Cor ®) was used 
for visualizing phosphorylated serines. 
Animal procedures 
All animal experimental procedures were approved by the Institutional Animal Care 
and Research Advisory Committee of the University of Leuven and performed 
according to the European guidelines. Following mouse strains were used: 
Prkar1atm2Gsm (Willis, Niswender, Su, Amieux, & McKnight, 2011), Tg(Cdh5-
cre/ERT2)1Rha (Wang et al., 2010) and ATG5flox/flox (Hara et al., 2006). All animals 
used in the experiments were of mixed N/FVB x C57/Bl6 background. Comparisons 
have been done between littermates only. For chloroquine rescue retinal 
angiogenesis experiment, pups were intraperitoneally injected with 50 l of 1mg/ml 
tamoxifen from postnatal day one (P1) to P3, and 100ul l of 1.25mg/ml chloroquine 
or PBS from P1 to P5. Mice were euthanized at P6, and dissection and staining of 
the retinas were performed as described below. For endothelial cells isolation, pups 
were intraperitoneally injected with 75 l of 1mg/ml tamoxifen daily from P7 until P10 
and the mice were euthanized at 8 weeks and endothelial cells were isolated as 
described below.  
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Retinal angiogenesis assay  
To analyse retinal angiogenesis , the procedures of isolation and staining of the 
retinas were performed as published(Pitulescu, Schmidt, Benedito, & Adams, 2010). 
Briefly, retinas were dissected in PBS and blocked/permeabilized in retina blocking 
buffer (1% BSA and 0.3% Triton X-100 in PBS) for 1-2 hours at room temperature. 
Alexa FluorTM 488 conjugated Isolectin GS-IB4(Invitrogen) diluted in Pblec solution 
(1mM MgCl2, 1mM CaCl2, 0.1mM MnCl2 and 1% Triton X-100 in PBS) was added to 
visualize whole-retina vasculature by incubating overnight at 4C, followed by 
staining for ESM1 (primary goat anti-ESM1 antibody; R&D Systems). After mounting, 
images of retinas were taken using a Leica SPE confocal microscope equipped with 
a HC PL APO 20X/0.75 IMM CORR CS2 objective or Leica SP8 confocal 
microscope equipped with a HCX IRAPO L 25X/0.95 W objective. Images were 
taken at room temperature using Leica LAS X software and processed with image J 
software.  
Endothelial cell isolation from liver or lung  
Livers or lung lobes were collected in dry 10cm dishes and minced finely with blades 
for one minute, and then incubated in 25ml of pre-warmed Dulbecco modified Eagle 
medium (4.5 g/L glucose with L-glutamine) containing 2 mg/mL collagenase 
(Invitrogen) in 50 ml tubes, gently shaking for 45 minutes at 37°C. Suspensions were 
passed through a 70μm cell strainer (VWR) and cells were spun down at 400g for 8 
minutes at 4°C. Pellets were resuspended in 10 ml Dulbecco modified Eagle 
medium containing 10% FBS, 50U/ml penicillin and 50μg/ml streptomycin, passed 
through 40μm Nylon cell strainer (BD Falcon, Cat. No. 352340) and centrifuged at 
400g for 8 minutes at 4°C. Cells were resuspended in cold DPBS (1ml/lung and 
2ml/liver), added to  sheep anti-Rat IgG-coupled Dynabeads (Invitrogen) pre-
incubated with purified Rat Anti-Mouse CD31 (BD Pharmingen) and incubated at 
4°C. for 20 min The beads were separated using a magnetic particle concentrator 
(Dynal MPC-S; Invitrogen)and washed with cold DPBS with 0.1% BSA. This washing 
step was repeated 5 times after which cells were lysed in RIPA buffer for Western 
Blotting.  
Statistical analysis  
.CC-BY 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/573683doi: bioRxiv preprint first posted online Mar. 12, 2019; 
  
Statistical analyses were performed using GraphPad Prism 7. The one-way ANOVA 
was used to compare more than two experimental groups.  
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Figure 1. Identification of direct substrates of PKACα. (A)Strategy for labeling, 
immunoprecipitation and identifying of PKACα substrates in HUVEC lysates. (B)Thio-phosphorylation 
of PKA substrates in HUVEC lysates expressing WT-PKACα or AS-PKACα for mass spectrometry 
analysis. Left panel (input) shows western blot analysis of lysates after alkylation before 
immunoprecipitation, middle panel (Elute) shows western blot analysis of the eluted proteins from the 
immunoprecipitation beads, right panel (Elute) shows the silver staining of the same samples as 
middle panel. (C)Validation of the six PKACα substrates identified in the chemical genetic approach 
screen by overexpressing of potential substrates and WT-PKACα (or AS-PKACα) in 293Tcells, and 
labeling the substrate in 293T cell lysates. Western blots are representative of two independent 
experiments. 
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thiophosphate with the electrophilic tag p-nitrobenzylmesylate
(PNBM) is concomitant with formation of undesired alkylation
products resulting from derivatization of cysteine thiols. To speci-
fically detect and purify thiophosphate reaction products, we
developed polyclonal and monoclonal antibodies that discriminate
thiophosphateestersfrom cysteinealkylation products(thioethers).
In our first report15, we had used this approach to detect
substratesof theserine-threoninekinase, Cdk1. To further develop
this strategy and expand theportion of the kinome tractablewith
thisapproach, weanalyzed each of the reaction steps (Fig. 1a) for
specificity and applicability to many kinase-substrate pairs. We
screened diverse kinases for the ability to thiophosphorylate their
protein ubstrate and found that thevast majority f kinas sused
ATPgS as a phosphodonor. We ynthesized orthogonal A*TPgS
analogsand found them to bepreferred ubstrates for ASkinases,
permitting delivery of thiophosphate to individual kinase sub-
strates. The resulting labeled kinase substrates, which contained
modified serine, threonine and tyrosine residues in the context of
diverse kinase consensus motifs, were all recognized by new
thiophosphate ester–specific antibodies. Our initial hapten design
presented the thiophosphate ester modification on a threonine
backbone15; the elicited hapten-specific
antibodies, however, suffered from either
lowyield of specificantibodyor lowaffinity,
and were not expected to recognize mod-
ified tyrosine residues. Here we designed a new hapten (Fig. 1b)
containing only theminimal desired epitope in an effort to focus
the immune response on the thiophosphate ester moiety. The
elicited rabbit polyclonal andmonoclonal antibodiesarethiosphos-
phate ester–specific, context-independent and capable of immu-
noprecipitation. Application of thissemisynthetic immunoaffinity
approach allowed usto purify thedirect substratesof an ASkinase
(Erk2), which wasexpressed at endogenous levels.
RESULTS
Generation of thiophosphate ester–specific IgG
Weelicited rabbit a-hapten–immunoglobulin gamma(IgG) with a
hapt n conjugate, consistingof ap-nitrobenzylthiophosphateester
with a three-carbon linker to keyhole limpet hemocyanin (KLH;
Fig. 1b). Affinity-purified polyclonal antibodies only recognized
c-Jun–GST containing both thiophosphorylation and PNBM
modifications (Fig. 1c), verifying that the antibodies discrimi-
nate thiophosphate alkylation products from all other possible
alkylation products. In contrast, antibodies raised in chicken
(a-hapten–IgY) recognized PNBM alkylated proteins whether or
not they had been thiophosphorylated (Supplementary Fig. 1
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Figure 1 | Strategy for labeling individual kinase substrates. (a) Reaction sequence for affinity tagging ASkinase substrates. First, an ASkinase (magenta)
usesN6-alkylat d ATPgS(A*TPgS) to thiophosphorylate its substrates (palemagenta). In a second step, alkylation with PNBMyields thiophosphate esters and
thioethers. Only ASkinase substrate are recognized by a-hapten–IgG. (b) Structure of the hapten conjugate used to elicit thiophosphate ester specific
antibodies. (c) JNK1 was incubated with c-Jun–GSTand combinations of ATPgSand PNBMas indicated; reaction productswere analyzed by western blot with
a-h pten–IgG. a-GST–IgGconfirms equal loading. Full-length blots are available in Supplementary Figure 1b.
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Figure 2 | Mass spectrometric analysis of
thiophosphorylated and alkylated c-Jun–GST.
(a) Sequence coverage of c-Jun-GST. Residues in
black were identified by automated database
searching of the unmodified peptides, blue
indicates peptides that contain amodified
cysteine, red indicates thiophosphate ester–
containing peptides, and residues in gray were
not observed. (b) Tandemmass spectrumof a
thioether–containing peptide. C* indicates a
nitrobenzyl-modified cysteine. (c) Tandemmass
spectrumof a peptide containing amodified
serine (S**), which corresponds to a site of JNK1
phosphorylation. A169-Da loss, consistent with
the depicted elimination, was observed from the
doubly charged molecular ion and also gave rise
to an additional y-ion series. Ions that have
undergone this loss are labeled in red.
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developed polyclonal and monoclonal antibodies that discriminate
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presented the thiophosphate ester modification on a threonine
backbone15; the elicited hapten-specific
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Figure 2 | Mass spectrometric analysis of
thiophosphorylated and alkylated c-Jun–GST.
(a) Sequence coverage of c-Jun-GST. Residues in
black were identified by automated database
searching of the unmodified peptides, blue
indicates peptides that contain amodified
cysteine, red indicates thiophosphate ester–
containing peptides, and residues in gray were
not observed. (b) Tandemmass spectrumof a
thioether–containing peptide. C* indicates a
nitrobenzyl-modified cysteine. (c) Tandemmass
spectrumof a peptide containing amodified
serine (S**), which corresponds to a site of JNK1
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the depicted elimination, was observed from the
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to an additional y-ion series. Ions that have
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Table 1. List of PKACa substrates  
Proteins are listed according to the log of fold changes of AS-PKACα to WT PKACα. Two 
independent experiments have been done to prepare the PKACα substrates samples for mass 
spectrometric analysis. The full list of proteins identified in both experiments is provided in Table S1.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 
Table 1. List of PKACa substrates
i are r i g to the log of fold changes of AS-PKACα to WT PKACα. Two independent
experiments have been done to prepare the PKACα substrates samples for mass spectrometric analysis.
The full list of proteins identified in both experiments is provided in Table S1.
U niprot Protein.nam es Gene.nam es Peptides
Log ratio AS/W T
experim ent1 experim ent2
Q6AI12 Ankyrin repeat domain-containing protein 40 ANKRD40 9 10 10
Q6P6C2 RNA demethylase ALKBH5 ALKBH5 6 10 10
Q9NRY4 Rho GTPase-activating protein 35 ARHGAP35 9 10 10
E7EVC7 Autophagy-related protein 16-1 ATG16L1 8 10 10
J3KPC8 Serine/threonine-protein kinase SIK3 SIK3;KIAA0999 5 10 10
A1X283 SH3 and PX domain-containing protein 2B SH3PXD2B 4 10 10
Q8IWZ8 SURP and G-patch domain-containing protein 1 SUGP1 5 10 10
Q9UJX5 Anaphase-promoting complex subunit 4 ANAPC4 5 10 10
O43719 HIV Tat-specific factor 1 HTATSF1 4 10 10
O95644-5 Nuclear factor of activated T-cells, cytoplasmic 1 NFATC1 5 10 10
G8JLI6 Prolyl 3-hydroxylase 3 LEPREL2 3 10 10
F8W781 Zinc finger CCCH domain-containing protein 13 ZC3H13 3 10 10
Q9BZL4 Protein phosphatase 1 regulatory subunit 12C PPP1R12C 21 6,04440274 7,30701515
O14974 Protein phosphatase 1 regulatory subunit 12A PPP1R12A 26 5,72796034 7,12654716
Q00537 Cyclin-dependent kinase 17 CDK17 31 6,37867381 6,39216838
Q9Y4G8 Rap guanine nucleotide exchange factor 2 RAPGEF2 21 10 6,17455504
Q9BYB0 SH3 and multiple ankyrin repeat domains protein 3 SHANK3 32 5,26591421 5,6389181
J3KSW8 Myosin phosphatase Rho-interacting protein MPRIP 18 4,61398477 5,61155414
P31323
cAMP-dependent protein kinase type II-beta regulatory 
subunit PRKAR2B 19 7,05077105 5,33509437
P13861
cAMP-dependent protein kinase type II-alpha regulatory 
subunit PRKAR2A 24 5,42841998 5,04010629
Q14980-2 Nuclear mitotic apparatus protein 1 NUMA1 61 3,45625969 4,47466712
O15056 Synaptojanin-2 SYNJ2 13 4,64022655 4,46069701
J3KNX9 Unconventional myosin-XVIIIa MYO18A 10 10 4,43208178
Q86UU1-2 Pleckstrin homology-like domain family B member 1 PHLDB1 19 5,4105243 4,10782285
P28715 DNA repair protein complementing XP-G cells ERCC5;BIVM-ERCC5 8 3,3571826 4,09305592
P12270 Nucleoprotein TPR TPR 104 3,3333472 4,04477536
Q15111
Inactive phospholipase C-like protein 1;
Phosphoinositide phospholipase C PLCL1 10 10 3,32188704
Q9HD67 Unconventional myosin-X MYO10 39 4,13973415 3,21827463
Q14185 Dedicator of cytokinesis protein 1 DOCK1 34 4,50413426 3,18515106
O75116 Rho-associated protein kinase 2 ROCK2 29 3,27701864 3,08277835
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Figure 2.PKACα phosphorylates ATG16L1α at S268 and ATG16L1β at S269. (A)Peptide SPOT 
assay of ATG16L1 phosphorylation sites screening. (B)Amino acid sequence including potential 
PKACα phosphorylation sites in ATG16L1α and ATG16L1β according to the peptide SPOT assay 
result of Figure 2A. (C-D)Identification of PKACα phosphorylation site in ATG16L1α(C) and 
ATG16L1β(D). Analysis was performed as in Figure 1C. Western blots are representative of two 
independent experiments. (E-F)Flag tagged ATG16L1α and ATG16L1β were thio-phosphorylated by 
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AS-PKACα and purified twice using M2 beads and thioP antibody coupled beads, followed by mass 
spectrometric analysis. LC-MS/MS spectra of the PKA- phosphorylated ATG16L1α tryptic peptide 
pSVSSFPVPQDNVDTHPGSGK and ATG16L1β tryptic peptide RLpSQPAGGLLDSITNIFGR. The 
results demonstrate that PKA phosphorylated ATG16L1α at S268 and phosphorylated ATG16L1β at 
S269.  
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Figure 3 
 
 
Figure 3. PKACα mediated phosphorylation of ATG16L1 facilitates its degradation whereas 
PKA deficiency stabilizes ATG16L1. (A-C) HUVECs infected with Flag ATG16L1a (WT or S268A) 
were treated with 250 mM 6-bnz-cAMP and 20 mg/ml CHX at the time points indicated when they 
reached confluence(A). Quantifications of Flag ATG16L1a WT(B) and S268A (C) expression. Data 
present the mean ± SD of 3 independent experiments. **P<0,01; ***P<0,001; ****P<0,0001. (D-F) 
HUVECs infected with Flag ATG16L1β (WT or S269A) were treated with 250 mM 6-bnz-cAMP and 20 
mg/ml CHX at the time points indicated when they reached confluence(D). Quantifications of Flag 
ATG16L1β WT(E) and S269A (F) expression. Data present the mean ± SD of 3 independent 
experiments. *P<0,05; **P<0,01; ***P<0,001. (G) HUVECs infected with shRNA(scramble or 
shPKACα) virus were lysed in RIPA buffer and proteins were analyzed by western blot using 
indicated antibodies. Western blots are representative of three independent experiments. (H) 
Endothelial cells isolated from mice(wild type or dnPKAiEC) were lysed in RIPA buffer and ATG16L1 
protein was analyzed by western blot.  
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Figure 4 
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Figure 4. Autophagy inhibition partially rescues retinal vascular hypersprouting caused by 
PKA deficiency. (A) Mice were injected with tamoxifen from P1 to P3, and retinas were collected at 
P6. Isolectin B4 and ESM1 staining of P6 retinas isolated from wtPKA and dnPKAiEC mice treated 
with PBS or CQ. Representative images are shown. (B-C) Quantifications of vascular area(B) and 
ESM1 positive area (C) per field of retinal fronts. 30-35 fields(images) taken from 6-7 retinas were 
measured for each group, ****P<0,0001. (D) Mice were injected with tamoxifen from P1 to P3, then 
retinas were collected at P6. Isolectin B4 and ESM1 staining of P6 retinas isolated from wtPKA with 
wtATG5 or ATG5ECKO mice and dnPKAiEC with wtATG5 or ATG5ECKO mice. Representative 
images are shown. (E-F) Quantifications of vascular area(B) and ESM1 positive area (C) per field of 
retinal fronts. Over 50 fields(images) taken from 8-10 retinas were measured for each group, 
***P<0,001;****P<0,0001.  
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Figure S1 
 
Figure S1. Screen for the best N6-substituted ATPgS analog as a phosphodonor of AS-PKACα 
(A)Kinase assay in HUVEC lysates using WT-PKACα and AS-PKACα. All the western blot 
membranes exposed at the same time. (B)Structural formulas of 7 different N6-substituted ATPgS 
analogs.  
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(A)Kinase assay in HUVEC lysates using WT-PKACα and AS-PKACα. All the western blot membranes exposed at the 
same time. 
(B)Structural formulas of 7 different N6-substituted ATPgS analogs. 
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Figure S2 
 
Figure S2. Thiophophorylation is converted to normal phosphoryation by 1% TFA acid–
promoted hydrolysis. (A-B)ATG16L1a(A) and ATG16L1β(B) thiophosphorylated and 
immunoprecopitated as in Figure 1C, then treated with or without 1% TFA at 37 °C for 4 hours.  
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Figure S2. Thiophophorylation is converted to norm al phosphoryation by 1% TFA acid–prom oted hydrolysis.
(A-B)ATG16L1a(A) and ATG16L1β(B) thiophosphorylated and immunoprecopitated as in Figure 1C, then treated
with or without 1% TFA at 37 °C for 4 hours.
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Figure S3 
 
Figure S3. Whole retina imagines of autophagy inhibition partially rescues retinal vascular 
hypersprouting caused by PKA deficiency. (A) wtPKA and dnPKAiEC mice treated with PBS or 
CQ were injected with tamoxifen from P1 to P3, then retinas were collected at P6. Vasculature was 
visualized with isolectin B4-Alexa Fluor 488. (B) wtPKA with wtATG5 or ATG5ECKO mice and 
dnPKAiEC with wtATG5 or ATG5ECKO mice were injected with tamoxifen from P1 to P3, then retinas 
were collected at P6. Vasculature was visualized with isolectin B4-Alexa Fluor 488.  
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Figure S3. W hole retina im agines of autophagy inhibition partially rescues retinal vascular hypersprouting
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(A) wtPKA and dnPKAiEC mice treated with PBS or CQ were injected with tamoxifen from P1 to P3, then retinas
were coll cted at P6. Vasculature was vis alized with isolectin B4-Alexa Fluor 488.
(B) wtPKA with wtATG5 or ATG5ECKO mice and dnPKAiEC with wtATG5 or ATG5ECKO mice were injected with
tamoxifen from P1 to P3, then retinas were collected a P6. Vasculature was vis alized with isolectin B4-Alexa
Fluor 488.
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